Sort
261,768 grants matching “gene therapy”
VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHES
$4,374,439Roy G. Brower · Johns Hopkins University · P50 · FY2006 · HL
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
$4,371,340Keith R Jerome · Fred Hutchinson Cancer Research Center · U19 · FY2015 · AI
Human Biochemical Genetics
$4,370,721William Gahl · National Human Genome Research Institute · ZIA · FY2015 · HG
Cancer Center Support Grant
$4,369,460Michelle M Le Beau · University Of Chicago · P30 · FY2010 · CA
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats
$4,367,220Jennifer A Doudna · University Of California Berkeley · U19 · FY2025 · NS
Molecular Biology of Human Lymphoid Malignancies
$4,365,837Louis Staudt · Clinical Sciences · Z01 · FY2007 · CA
VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHES
$4,363,616Johns Hopkins University · P50 · FY2005 · HL
Neurobiological Predictors of Huntington's Disease
$4,359,483University Of Iowa · R01 · FY2005 · NS
Adult Leukemia Research Center
$4,359,202Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Cold Spring Harbor Laboratory Cancer Research Center
$4,358,993Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2007 · CA
VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHES
$4,354,411Roy G. Brower · Johns Hopkins University · P50 · FY2007 · HL
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$4,353,842Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2021 · CA
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$4,353,212Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
CSHL CANCER CENTER SUPPORT GRANT
$4,346,720Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2012 · CA
Cold Spring Harbor Laboratory Cancer Research Center
$4,344,544Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$4,343,433Howard Feldman · University Of California, San Diego · R01 · FY2021 · AG
The CRISPR Vision Program: Nonviral Genome Editing Platforms to Treat Inherited Retinal Channelopathies
$4,343,177Krishanu Saha · University Of Wisconsin-Madison · U19 · FY2025 · NS
Preclinical Genome Editing for Rare Neurological Diseases
$4,319,346Cathleen M Lutz · Jackson Laboratory · U19 · FY2025 · NS
Pathogenic Mechanisms in Spondyloarthritis
$4,318,760Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Genetic Basis Of Cortical Malfunction In Schizophrenia
$4,316,676Daniel Weinberger · National Institute Of Mental Health · ZIA · FY2010 · MH
GENERAL CLINICAL RESEARCH CENTER
$4,310,049Gerald S Levey · University Of California Los Angeles · M01 · FY2006 · RR
Alzheimer's Disease Genetics Consortium
$4,308,755Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2015 · AG
Germline variation in homologous recombination repair genes in Hispanic/Latina women to predict breast cancer risk and response to treatment
$4,307,388Elad Ziv · University Of California, San Francisco · R01 · FY2025 · MD
CSHL CANCER CENTER SUPPORT GRANT
$4,306,037Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2011 · CA
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$4,303,502Ali Naji · University Of Pennsylvania · U01 · FY2025 · AI